Close

News

BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases

BioVaxys Technology Corp. highlights the potential of its novel lipid-in-oil delivery platform, DPXâ„¢, across multiple infectious disease studies and announces its plans for partnering and further development. BioVaxys' DPXâ„¢ technology is a patented delivery platform that can incorporate a range...

Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program

Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen's DNA-encoded...

Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent

Bora Pharmaceuticals Co., Ltd., a a global leader in pharmaceutical manufacturing announced that it has completed the acquisition from Emergent BioSolutions of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive biologics...

PCI Pharma Services Successfully Completes International Inspection of New Hampshire Campus

PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), announced in a press release on Aug. 21, 2024 that its Bedford, NH campus successfully completed the multi-agency inspection process of the International Coalition of Medicines Regulatory Authorities...

FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham. This new facility triples existing...

Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine

Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a collaboration with specialist company, Touchlight, who will provide new technology to to produce large quantities of the DNA...

RedHill announces launch of Talicia in UAE to treat bacterial infection

RedHill Biopharma Ltd. , a specialty biopharmaceutical company announced the launch of Talicia (omeprazole magnesium, amoxicillin and rifabutin) in the United Arab Emirates (UAE) – making it available by prescription to treat adults with Helicobacter pylori (H. pylori) infection....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read